R Češka
Impact in
- Surgery top 0.5%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Surgery 98
- Lipoproteins and Cardiovascular Health 92
-
- Cancer, Lipids, and Metabolism 44
- Co-authors
- Michal Vráblík (74 shared papers)Scott M. Wasserman (5 shared papers)Tomáš Štulc (42 shared papers)Ioanna Gouni‐Berthold (7 shared papers)Marc S. Sabatine (9 shared papers)Robert P. Giugliano (8 shared papers)Terje R. Pedersen (6 shared papers)Anthony Keech (5 shared papers)
- Journals
- Physiological Research (20 papers)Atherosclerosis Supplements (8 papers)Current Atherosclerosis Reports (6 papers)Atherosclerosis (6 papers)Clinica Chimica Acta (4 papers)
- Partner nations
- CzechiaUnited StatesUnited Kingdom
In The Last Decade
R Češka
166 papers receiving 4.6k citations
R Češka's Hit Papers
Peers
Comparison fields: 5 of 121
- Surgery 3.4k
- Endocrinology, Diabetes and Metabolism 1.3k
- Cancer Research 742
- Cardiology and Cardiovascular Medicine 1.1k
- Economics and Econometrics 1000
Countries citing papers authored by R Češka
This map shows the geographic impact of R Češka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Češka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Češka more than expected).
Fields of papers citing papers by R Češka
This network shows the impact of papers produced by R Češka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Češka. The network helps show where R Češka may publish in the future.
Co-authors
The 25 scholars most cited alongside R Češka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 174 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Hit paper breakdown → | 2019 | 585 |
| 2 | A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia Hit paper breakdown → | 2014 | 553 |
| 3 | Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial Hit paper breakdown → | 2017 | 469 |
| 4 | ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia Hit paper breakdown → | 2015 | 418 |
| 5 | Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance Hit paper breakdown → | 2016 | 354 |
| 6 | 2000 | 265 | |
| 7 | 2012 | 176 | |
| 8 | 2018 | 99 | |
| 9 | 2014 | 88 | |
| 10 | 2020 | 81 | |
| 11 | 2019 | 75 | |
| 12 | 2005 | 64 | |
| 13 | 2011 | 53 | |
| 14 | 2014 | 47 | |
| 15 | Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis. | 2000 | 45 |
| 16 | 2015 | 42 | |
| 17 | 2012 | 39 | |
| 18 | New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels. | 2004 | 35 |
| 19 | Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis. | 2001 | 32 |
| 20 | 2008 | 31 |
About R Češka
R Češka is a scholar working on Surgery, Cancer Research, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Genetics, having authored 174 papers that have together received 4.8k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (92 papers), Cancer, Lipids, and Metabolism (44 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Lipid metabolism and disorders (16 papers), Pharmaceutical Economics and Policy (13 papers), Nutrition, Genetics, and Disease (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Cardiovascular Health and Disease Prevention (10 papers). The work is most often cited by research in Surgery (3.4k citations), Endocrinology, Diabetes and Metabolism (1.3k citations), Cancer Research (742 citations), Cardiology and Cardiovascular Medicine (1.1k citations) and Economics and Econometrics (1000 citations). R Češka has collaborated with scholars based in Czechia, United States and United Kingdom. Frequent co-authors include Michal Vráblík, Scott M. Wasserman, Tomáš Štulc, Ioanna Gouni‐Berthold, Marc S. Sabatine, Robert P. Giugliano, Terje R. Pedersen, Anthony Keech, Dirk Blom and Lesley Burgess. Their work appears in journals such as Physiological Research, Atherosclerosis Supplements, Current Atherosclerosis Reports, Atherosclerosis and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.